Tesofensine for fat loss: what the trials actually showed

What did @claremorrow_ifbbpro actually say?

Clare called tesofensine "a great peptide" that is "amazing" for fat loss and "tremendous for your cravings." She described it as a pill that is "not super expensive" and invited viewers to DM her to obtain it. That last part is where things get legally and medically complicated, fast.

First, a terminology correction worth making: tesofensine is not a peptide. It is a small-molecule reuptake inhibitor, chemically distinct from peptide-based compounds like semaglutide or tirzepatide. Calling it a peptide is not just imprecise, it is factually wrong, and in a space where these distinctions affect how compounds are regulated and compounded, accuracy matters. The DM-to-purchase model she is describing is also a significant red flag for anyone thinking about patient safety and regulatory compliance.

Does the science back this up?

There is real early-phase trial data supporting tesofensine's appetite-suppressing effects, but calling it "amazing" dramatically overstates where the evidence actually stands. This drug has not cleared Phase 3 trials or received FDA approval for any indication.

The most cited human data comes from Astrup et al. (2008, The Lancet), a Phase 2 trial showing dose-dependent weight loss of 6.5 to 12.8 kg over 24 weeks compared to 2.2 kg on placebo. That is a genuinely meaningful signal. Tesofensine works by inhibiting reuptake of serotonin, dopamine, and norepinephrine, which suppresses appetite through central nervous system pathways. However, the same trial flagged elevated heart rate and blood pressure as concerns, and no large-scale Phase 3 data in humans exists publicly. A 2012 study by Lehr et al. in Obesity Reviews noted that cardiovascular safety signals kept development stalled. The mechanism is real. The "amazing" label is not yet earned by the evidence base.

What did they get wrong (or right)?

She got the core mechanism directionally right: tesofensine does appear to reduce appetite and drive weight loss in early human trials. Credit where it is due. But the errors here are not minor footnotes.

• Calling it a peptide is flat-out incorrect. Tesofensine is a small-molecule triple monoamine reuptake inhibitor, not a peptide. This is a basic pharmacology error.
• Describing it as "not super expensive" with no context about sourcing, quality, or legality is irresponsible. Tesofensine is not FDA-approved and is not legally available through licensed U.S. pharmacies for weight loss. What is being sold through DMs is almost certainly a research chemical or gray-market compound with no verified purity or dosing standards.
• Offering to supply it via direct message raises serious legal and safety concerns. Selling unapproved drugs without a valid prescriber-patient relationship and pharmacy dispensing chain is not a gray area. It is illegal under federal law.

The enthusiasm here is running well ahead of both the evidence and the regulatory reality.

What should you actually know?

Tesofensine is an investigational compound with a plausible mechanism and early positive data, not an approved weight loss drug. The distinction matters for your safety, not as regulatory bureaucracy.

The cardiovascular concerns flagged in Astrup et al. (2008) are real. Elevated heart rate and increased blood pressure were observed even in a controlled trial setting with screened participants. Obtaining this compound through social media DMs means zero quality control, no verified dosing, no medical supervision, and no recourse if something goes wrong. A 2023 review by Syed et al. in Current Obesity Reports noted that tesofensine's development pipeline remains stalled largely because of these cardiovascular safety questions.

If you are interested in medically supervised appetite management, there are FDA-approved options, including GLP-1 receptor agonists like semaglutide and tirzepatide, with far more robust trial data behind them. A licensed telehealth provider can assess whether those are appropriate for you. Buying unapproved compounds from an IFBB pro's DMs is a very different thing from medical care.